Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04253418 · ClinicalTrials.gov registry record · NA
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study
A NA study, sponsored by Pulse Biosciences.
- Terminated
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT04253418: Clinical Trial NA study, sponsored by Pulse Biosciences.
NCT04253418 is a NA study that was terminated before completion, run by Pulse Biosciences. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04253418, a NA study, was terminated before completion, sponsored by Pulse Biosciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.
Primary Outcome
Clearance of SH lesions treated with NPS as rated by investigators.
Interventions
- DEVICE Nano-Pulse Stimulation (NPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
Why NCT04253418 stopped before completion
NCT04253418 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Nano-Pulse Stimulation (NPS) is the first listed.
NCT04253418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04253418 about?
NCT04253418 is a clinical study titled "Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study". Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.
What is the current status of trial NCT04253418?
This trial is currently terminated. It is a NA study. The enrollment target is 125 participants. The study started on 2018-12-20. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT04253418?
The interventions under investigation include: Nano-Pulse Stimulation (NPS) (DEVICE).
Who is sponsoring clinical trial NCT04253418?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04253418's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI